Inventor · disambiguated record
Franklin Bymaster
Also filed as: BYMASTER FRANKLIN · BYMASTER FRANKLIN P · BYMASTER FRANKLIN PORTER
31 granted patents·8 pending applications·318 citations·filing 1994–2020
97Inventor score
Files withLILLY CO ELI18MCKINNEY ANTHONY ALEXANDER5NOVO NORDISK AS5NEUROVANCE INC3OTSUKA AMERICA PHARMACEUTICAL INC3
Top patents by PatentIndex Score
39 records- 0188US9708261B2Crystalline compoundsNEUROVANCE INC·Filed 2016·Granted Jul 18, 2017·6 cites·32 claims
- 0287US10800740B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2019·Granted Oct 13, 2020·2 cites·26 claims
- 0387US6147072ACombination therapy for treatment of psychosesLILLY CO ELI·Filed 1997·Granted Nov 14, 2000·79 cites·22 claims
- 0486US9856217B2Crystalline compoundsNEUROVANCE INC·Filed 2017·Granted Jan 2, 2018·4 cites·14 claims
- 0585US11299458B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2020·Granted Apr 12, 2022·1 cites·10 claims
- 0684US10280141B2Crystalline compoundsOTSUKA AMERICA PHARMACEUTICAL INC·Filed 2017·Granted May 7, 2019·3 cites·40 claims
- 0780US9839627B2Methods of treating fragile X associated disorders, ADHD, and autism spectrum disorderNEUROVANCE INC·Filed 2014·Granted Dec 12, 2017·6 cites·20 claims
- 0875US5488056AMethod for treating anxietyLILLY CO ELI·Filed 1994·Granted Jan 30, 1996·45 cites·9 claims
- 0971US5858393ATransdermal formulationLILLY CO ELI·Filed 1997·Granted Jan 12, 1999·29 cites·13 claims
- 1069US2021046044A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2020·Application pending·0 cites
- 1165US5852037AMethod for treating anxietyLILLY CO ELI·Filed 1996·Granted Dec 22, 1998·29 cites·34 claims
- 1262US2014315892A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2014·Application pending·0 cites
- 1361US2018296527A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2017·Application pending·0 cites
- 1459US5605701ATransdermal formulationLILLY CO ELI·Filed 1995·Granted Feb 25, 1997·20 cites·14 claims
- 1558US2017216251A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disordersMCKINNEY ANTHONY ALEXANDER·Filed 2016·Application pending·0 cites
- 1656US5484794AMethod for treating anxietyLILLY CO ELI·Filed 1994·Granted Jan 16, 1996·5 cites·1 claims
- 1751US5763457AMethod for treating anxietyLILLY CO ELI·Filed 1996·Granted Jun 9, 1998·14 cites·18 claims
- 1850US5980933ATransdermal formulation of xanomelineELI LIILY AND COMPANY·Filed 1997·Granted Nov 9, 1999·11 cites·20 claims
- 1950US2003022889A1Method for providing neuro-protective effectsFiled 2002·Application pending·0 cites
- 2049US6117890AMethod for treating bipolar disorderLILLY CO ELI·Filed 1997·Granted Sep 12, 2000·10 cites·8 claims
- 2149US5888999AMethod for treating anxiety with muscarinic cholinergic receptor agonistsLILLY CO ELI·Filed 1997·Granted Mar 30, 1999·8 cites·18 claims
- 2248US2004023951A1Combination therapy for treatment of psychosesFiled 2001·Application pending·0 cites
- 2347US5677313AAntipsychotic methodNOVO NORDISK AS·Filed 1995·Granted Oct 14, 1997·5 cites·8 claims
- 2445US5679686AAntipsychotic methodNOVO NORDISK AS·Filed 1995·Granted Oct 21, 1997·2 cites·13 claims
- 2544US6043258AMethod for treating disruptive behavior disorders with xanomelineLILLY CO ELI·Filed 1997·Granted Mar 28, 2000·7 cites·14 claims
- 2644US5574028AMethod for treating anxietyLILLY CO ELI·Filed 1994·Granted Nov 12, 1996·7 cites·1 claims
- 2744US2017209415A1Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive disorders including nicotine addictionMCKINNEY ANTHONY ALEXANDER·Filed 2016·Application pending·0 cites
- 2841US6090829AMethod for treating excessive aggressionLILLY CO ELI·Filed 1997·Granted Jul 18, 2000·5 cites·10 claims
- 2940US5968926AAntipsychotic methodNOVO NORDISK AS·Filed 1995·Granted Oct 19, 1999·1 cites·11 claims
- 3039US6034108AMethod for treating mental retardationLILLY CO ELI·Filed 1997·Granted Mar 7, 2000·4 cites·17 claims
- 3139US5708014AMethod for treating anxietyLILLY CO ELI·Filed 1994·Granted Jan 13, 1998·6 cites·7 claims
- 3239US2005009925A1Use of norepinephrine reuptake inhibitors for the treatment of cognitive failureFiled 2002·Application pending·0 cites
- 3338US5750541AMethod of treating schizophreniaNOVO NORDISK AS·Filed 1996·Granted May 12, 1998·3 cites·11 claims
- 3436US5852036AMethod for treating anxietyLILLY CO ELI·Filed 1995·Granted Dec 22, 1998·2 cites·4 claims
- 3534US5753683AAntipsychotic methodNOVO NORDISK AS·Filed 1996·Granted May 19, 1998·1 cites·17 claims
- 3634US5574053AMethod for treating anxietyLILLY CO ELI·Filed 1995·Granted Nov 12, 1996·1 cites·1 claims
- 3733US5574029AMethod for treating anxietyLILLY CO ELI·Filed 1995·Granted Nov 12, 1996·1 cites·1 claims
- 3832US5726193AMethod for treating anxietyLILLY CO ELI·Filed 1995·Granted Mar 10, 1998·1 cites·4 claims
- 3931US5663182AAntipsychotic methodFiled 1996·Granted Sep 2, 1997·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →